International Center for Neurological Restoration, Cuba Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT01010802
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

International Center for Neurological Restoration | International Center for Neurological Restoration, Cuba

Active Ingredients

Drugs in Phase 2 Trials (1)

epoetin (Epogen) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1